This is a StreetInsider.com Premium Only Page

(ETTX) – StreetInsider.com Reports

Jun 9, 2022 08:01 AM Entasis Therapeutics Holdings Inc. (ETTX) Presents Data on Sulbactam-Durlobactam and ETX0462

May 23, 2022 08:58 AM Entasis Therapeutics Holdings Inc. (ETTX) to Resume Trading at 9 a.m.

May 23, 2022 08:31 AM Innoviva (INVA) to Acquire Entasis Therapeutics (ETTX) for $2.20 in Cash

May 23, 2022 08:00 AM Entasis Therapeutics Holdings Inc. (ETTX) Halted, News Pending

May 17, 2022 08:01 AM Entasis Therapeutics Holdings Inc. (ETTX) Reports Data Highlights from Phase 3 ATTACK Trial

May 6, 2022 03:33 AM Cantor Fitzgerald Downgrades Entasis Therapeutics (ETTX) to Neutral

Apr 26, 2022 08:01 AM Entasis Therapeutics Holdings Inc. (ETTX) Reports Efficacy and Safety Data from Phase 3 ATTACK Trial

Apr 18, 2022 08:30 AM Entasis Therapeutics Holdings Inc. (ETTX) Reports SUL-DUR Topline Data from Phase 3 ATTACK Trial

Mar 16, 2022 07:10 AM Alliance Global Partners Downgrades Entasis Therapeutics (ETTX) to Neutral

Mar 8, 2022 06:14 AM Wedbush Downgrades Entasis Therapeutics (ETTX) to Neutral

Mar 4, 2022 06:15 AM UPDATE: H.C. Wainwright Downgrades Entasis Therapeutics (ETTX) to Neutral

Mar 3, 2022 12:21 PM Cantor Fitzgerald Reiterates Entasis Therapeutics (ETTX) at Overweight, Believes More Value to Unlocked in Shares

Mar 3, 2022 07:37 AM Entasis Therapeutics Holdings Inc. (ETTX) Provides Provides Business Update, Reports 2021 Year End Results

Feb 2, 2022 04:34 PM Entasis Therapeutics (ETTX) Receives Acquisition Proposal from Existing Majority Stockholder Innoviva

Nov 24, 2021 01:07 PM Entasis Therapeutics Holdings Inc. (ETTX) granted European patent number EP3630111 titled "COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS - Patent Grants

Oct 19, 2021 11:58 AM Entasis Therapeutics (ETTX) PT Raised to $7 at BMO Capital

Oct 19, 2021 09:22 AM Pre-Open Stock Movers 10/19: (WATT) (ETTX) (HRMY) Higher; (AVIR) (GRTX) (MGNI) Lower (more...)

Oct 19, 2021 09:00 AM Zai Lab Limited (ZLAB) and Entasis (ETTX) Reports Positive Topline Results for Sulbactam-Durlobactam (SUL-DUR) from Phase 3 ATTACK Trial

Oct 19, 2021 06:48 AM Entasis Therapeutics (ETTX) PT Raised to $9 at Wedbush

Oct 19, 2021 06:41 AM Entasis Therapeutics (ETTX) PT Raised to $6 at H.C. Wainwright

Oct 18, 2021 06:13 PM After-Hours Stock Movers 10/18: (ETTX) (DRMA) (STLD) Higher; (TASK) (EVER) Lower (more...)

Oct 18, 2021 04:06 PM Entasis Therapeutics Holdings Inc. (ETTX) study of sulbactam-durlobactam from Phase 3 ATTACK trial meets primary endpoint

Oct 18, 2021 04:02 PM Entasis Therapeutics Holdings Inc. (ETTX) Halted, News Pending

Aug 2, 2021 04:54 PM Entasis Therapeutics Holdings Inc. (ETTX) Files for up to $47M Offering

Jun 18, 2021 08:02 AM Entasis Therapeutics (ETTX) Introduces First-in-Class Candidate, ETX0462, and Presents Data on SUL-DUR and ETX0282CPDP at World Microbe Forum

May 6, 2021 01:30 PM Entasis Therapeutics (ETTX) PT Lowered to $6 at Wedbush, Following Earnings

Mar 23, 2021 02:46 PM Entasis Therapeutics (ETTX) PT Lowered to $5 at Credit Suisse, Following Earnings

Nov 16, 2020 07:26 AM Alliance Global Partners Starts Entasis Therapeutics (ETTX) at Buy

Nov 6, 2020 11:53 AM Entasis Therapeutics (ETTX) PT Lowered to $8 at Roth Capital, Following Earnings

Nov 6, 2020 06:06 AM Entasis Therapeutics (ETTX) PT Lowered to $6.50 at Credit Suisse

Sep 8, 2020 04:04 PM Cantor Fitzgerald Starts Entasis Therapeutics (ETTX) at Overweight

Aug 28, 2020 08:02 AM Entasis Therapeutics Holdings Inc. (ETTX) Announces $25 Million Private Placement of Common Stock, Warrants

Jul 13, 2020 07:44 AM Roth Capital Starts Entasis Therapeutics (ETTX) at Buy

Jul 6, 2020 08:05 AM Entasis Therapeutics Holdings Inc. (ETTX) Secures Initial $3M Contract from NIH to Expand Scope of NBP Program; Contract Max Value Up to $15.5M

Apr 14, 2020 07:23 AM Entasis Therapeutics (ETTX) PT Lowered to $5 at H.C. Wainwright

Mar 12, 2020 03:54 PM Entasis Therapeutics (ETTX) PT Lowered to $11 at Wedbush

Sep 30, 2019 06:32 AM Entasis Therapeutics Holdings Inc. (ETTX), GARDP Commence Global Phase 3 Trial of Zoliflodacin

Aug 19, 2019 07:21 AM H.C. Wainwright Starts Entasis Therapeutics (ETTX) at Buy

Aug 12, 2019 07:33 AM Entasis Therapeutics Holdings Inc. (ETTX) Misses Q2 EPS by 42c

Aug 5, 2019 05:24 PM Entasis Therapeutics Holdings Inc. (ETTX) Announces Dr. Howard Mayer to Board

Jun 27, 2019 08:05 AM Entasis Therapeutics Holdings Inc. (ETTX) Reports New Data Supporting Advancement of Multiple Pathogen-Targeted Antimicrobial Programs

Jun 24, 2019 08:04 AM Entasis Therapeutics Holdings Inc. (ETTX) Announces David Meek as Board Chairman

Jun 13, 2019 08:04 AM Entasis Therapeutics Holdings Inc. (ETTX) Reports Initial ETX0282 Phase 1 Results

Apr 4, 2019 08:02 AM Entasis Therapeutics Holdings Inc. (ETTX) Begins Global Phase 3 Pivotal Trial of ETX2514SUL for Patients with Carbapenem-Resistant Acinetobacter Infections

Feb 5, 2019 08:07 AM Entasis Therapeutics Holdings Inc. (ETTX) Reports Positive Feedback from FDA End-of-Phase 2 Meeting for ETX2514SUL; Sign Rapid Diagnostic Agreement with bioMerieux

Nov 7, 2018 05:28 PM Entasis Therapeutics Holdings Inc. (ETTX) Reports Publication of Zoliflodacin Phase 2 Results in The New England Journal of Medicine

Oct 24, 2018 06:23 AM UPDATE: SunTrust Robinson Humphrey Starts Entasis Therapeutics (ETTX) at Buy

Oct 22, 2018 08:15 AM Credit Suisse Starts Entasis Therapeutics (ETTX) at Outperform

Oct 22, 2018 06:26 AM Wedbush Starts Entasis Therapeutics (ETTX) at Outperform

Oct 22, 2018 02:10 AM BMO Capital Starts Entasis Therapeutics (ETTX) at Outperform